Back to Authors

Suter, Lisa

0000-0002-4898-6783

Mayo Clinic

Yale School of Medicine, New Haven, Connecticut, and Veterans Administration Hospital, West Haven, Connecticut.

Citations 1

Development of the American College of Rheumatology Patient‐Reported Outcome Quality Measures for Systemic Lupus Erythematosus
Katz, Patricia , Barber, Claire , Duarte‐García, Alí , Garg, Shivani , Machua, Wambui, Rodgers, Wendy, Santiago‐Casas, Yesenia, Suter, Lisa G., Bartels, Christie M. , Yazdany, Jinoos , Katz, Patricia , Barber, Claire E H , Suter, Lisa , Duarte-García, Alí , Yazdany, Jinoos , Bartels, Christie M , Garg, Shivani

Arthritis Care & Research | January 15, 2024 | Volume: 76 | Issue: 6 | Pages: 777-787

10.1002/acr.25301 Get It

Objective As part of a Centers for Disease Control and Prevention–funded American College of Rheumatology (ACR) initiative, we sought to develop quality measures related to Patient Reported Outcome Measure (PROM) use for systemic lupus erythematosus (SLE) clinical care. Methods An expert workgroup composed of physician, patient, and researcher representatives convened to identify patient‐reported outcome (PRO) domains of greatest importance to people with SLE. A patient advisory panel separately ranked domains. PROMs assessing priority domains were identified through structured literature review, and detailed psychometric reviews were conducted for each PROM. In a Delphi process, the expert workgroup rated PROMs on content validity, psychometric quality, feasibility of implementation, and importance for guiding patient self‐management. The patient advisory panel reviewed PROMs in parallel and contributed to the final recommendations. Results Among relevant PRO domains, the workgroup and patient partners ranked depression, physical function, pain, cognition, and fatigue as high‐priority domains. The workgroup recommended at least once yearly measurement for (1) assessment of depression using the Patient Health Questionnaire or Patient Reported Outcomes Measurement Information System (PROMIS) depression scales; (2) assessment of physical function using PROMIS physical function scales or the Multi‐Dimensional Health Assessment Questionnaire; and (3) optional assessments of fatigue and cognition. Pain scales evaluated were not found to be sufficiently superior to what is already assessed in most SLE clinic visits. Conclusion Expert workgroup members and patient partners recommend that clinicians assess depression and physical function at least once yearly in all people with SLE. Additional PROMs addressing cognition and fatigue can also be assessed. Next steps are to incorporate PROM‐based quality measures into the ACR The Rheumatology Informatics System for Effectiveness registry.